Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription 06.04.2026 1 Abdom Radiol (NY) 1 Ann Agric Environ Med 1 Ann Med 2 Anticancer Res 1 Biochim Biophys Acta Rev Cancer 1 Biomark Res 2 Biomedicines 1 Bioorg Chem 1 BJOG 1 BMC Health Serv Res 1 BMC Public Health 1 Cancer Causes Control 1 Cancer Epidemiol Biomarkers Prev 1 Cancer Med 1 Cancer Res 1 Cancers (Basel) 1 Chem Biol Interact 1 Clin Oncol (R Coll Radiol) 1 Clin Ther 1 Comput Biol Med 1 Cureus 1 Diagnostics (Basel) 1 Expert Rev Anticancer Ther 1 Expert Rev Mol Diagn 1 FASEB J 1 Front Cell Infect Microbiol 1 Front Med (Lausanne) 2 Front Oncol 1 Front Pharmacol 1 Front Surg 1 Future Med Chem 2 Future Oncol 1 Genes (Basel) 1 Gynecol Oncol 1 Gynecol Oncol Rep 1 Hum Vaccin Immunother 1 IET Syst Biol 1 Indian J Pathol Microbiol 1 Indian Pediatr 1 Infect Agent Cancer 1 Int J Biol Macromol 2 Int J Gynaecol Obstet 1 Int J Nanomedicine 1 Int J Technol Assess Health Care 1 Int J Womens Health 2 J Cancer Res Ther 2 J Gynecol Oncol 1 J Med Internet Res 1 J Med Virol 1 J Natl Cancer Inst 2 J Natl Compr Canc Netw 1 J Obstet Gynaecol Res 1 J Radiat Res 1 J Transl Med 1 JMIR Form Res 1 Life (Basel) 1 Med J Aust 1 Med Phys 1 Med Sci (Basel) 1 Oncol Lett 1 Oncol Rep 2 Pharmaceuticals (Basel) 1 PLoS One 2 Radiat Oncol 2 Radiol Imaging Cancer 1 Recent Pat Anticancer Drug Discov 3 Sci Rep 2 Support Care Cancer 1 Talanta 1 Vaccine 1 Vaccines (Basel) 1 Yakugaku Zasshi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Abdom Radiol (NY)

1. YANG T, Zhang T, Yan W, Chen X, et al
   DWI-derived intratumoral, peritumoral, and habitat features for preoperative prediction of lymph node metastasis in early-stage cervical cancer using machine learning method.
   Abdom Radiol (NY). 2026 Mar 27. doi: 10.1007/s00261-026-05463.
   PubMed         Abstract available
   
   

   
   Ann Agric Environ Med

2. GOTLIB-MALKOWSKA J, Debska M
   Effectiveness of ChatGPT in simplifying information for Polish patients on cervical cancer screening using advanced prompting.
   Ann Agric Environ Med. 2026;33:46-52.
   PubMed         Abstract available
   
   

   
   Ann Med

3. RAKHMANOVA M, Sakko Y, Suleimenova A, Sakhipova G, et al
   Patient acceptance of HPV self-sampling approach for cervical cancer screening: evidence from a pilot study in Kazakhstan.
   Ann Med. 2026;58:2645175.
   PubMed         Abstract available
   
   

   
   Anticancer Res

4. PARKER JM, Williams LR, Haines NA, Mayberry TG, et al
   Unveiling the Molecular Blueprint of Spinach Induced Anti-proliferation and Pro-apoptosis in Cervical Cancer.
   Anticancer Res. 2026;46:1833-1841.
   PubMed         Abstract available
   
   
5. SARKAR S, Saha A, DAS B, DAS D, et al
   Phosphodiesterase 5 Inhibitor Sildenafil Inhibits HPV(+) Cervical Cancer Cells and Cervical Cancer Stem Cells by Apoptotic Induction and Telomerase Activity Modulation.
   Anticancer Res. 2026;46:2007-2024.
   PubMed         Abstract available
   
   

   
   Biochim Biophys Acta Rev Cancer

6. ZHANG Y, Li C, Xiang Y
   Tumor immune microenvironment in cervical cancer: Histological subtype-specific immune landscapes and therapeutic implications.
   Biochim Biophys Acta Rev Cancer. 2026 Apr 1:189581.
   PubMed         Abstract available
   
   

   
   Biomark Res

7. YANG T, Guo L, Liu D, Hua K, et al
   Proteome-based molecular subtyping and therapeutic target prediction in cervical cancer.
   Biomark Res. 2026;14:35.
   PubMed         Abstract available
   
   

   
   Biomedicines

8. MOLNAR O, Mihutiu S, Straciuc OM, Vesa A, et al
   Correction: Molnar et al. PET CT Imaging with FDG in the Therapeutical Management of Locally Advanced Cervical Cancer Diagnosed in a 43-Year-Old Patient: Case Report and Review of the Literature. Biomedicines 2025, 13, 83.
   Biomedicines. 2026;14:676.
   PubMed         Abstract available
   
   
9. TAN L, Li H, Liu T, Mao W, et al
   Perineural Invasion in Early-Stage Cervical Cancer: Marker of Aggressive Pathology and Increased Recurrence Risk.
   Biomedicines. 2026;14:591.
   PubMed         Abstract available
   
   

   
   Bioorg Chem

10. WANG D, He J, Wu S, Liu S, et al
    UM-6 remodels the tumor immune microenvironment by blocking PD-L1 N-glycosylation and promoting ERAD-mediated degradation in cervical cancer.
    Bioorg Chem. 2026;175:109788.
    PubMed         Abstract available
    
    

    
    BJOG

11. CHU K, Vidali S, Parberry A, Saull M, et al
    Evaluation of the Quality and Suitability of Self-Collected Vaginal and Urine Samples for Human Papillomavirus Testing: A Prospective Matched Study.
    BJOG. 2026;133:1262-1270.
    PubMed         Abstract available
    
    

    
    BMC Health Serv Res

12. HALLSSON LR, Hoflacher AM, Stratil J, Muehler M, et al
    Cost-effectiveness studies evaluating HPV self-sampling for cervical cancer screening - a systematic review.
    BMC Health Serv Res. 2026 Mar 28. doi: 10.1186/s12913-026-14409.
    PubMed        
    
    

    
    BMC Public Health

13. BRIN M, Caraballo PB, Ramirez SO, Guzman L, et al
    Evaluation of a patient educational brochure to increase knowledge of cervical cancer screening among women living with HIV in La Romana.
    BMC Public Health. 2026 Mar 28. doi: 10.1186/s12889-026-27029.
    PubMed        
    
    

    
    Cancer Causes Control

14. JIN W, Wang X, Fan Y, Huang C, et al
    A preference study for applying mHealth to improve the quality of cervical cancer screening management from a supply and demand perspective: a discrete choice experiment.
    Cancer Causes Control. 2026;37:70.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

15. JIA X, Da X, Shi J, Chen M, et al
    Real-World Performance of HPV DNA-Based Screening in Health Resource-Limited Areas of China: A Multicenter Implementation Study.
    Cancer Epidemiol Biomarkers Prev. 2026;35:528-539.
    PubMed         Abstract available
    
    

    
    Cancer Med

16. MATSUKAWA H, Yugawa K, Hosokawa C, Furuichi K, et al
    Hyperspectral Imaging of Whole-Cell Region for Differentiating Cervical Squamous Intraepithelial Lesion Cytology.
    Cancer Med. 2026;15:e71746.
    PubMed         Abstract available
    
    

    
    Cancer Res

17. KLOPP AH
    Longitudinal Profiling of Cervical Cancers Reveals Therapy-Induced Vulnerabilities Beyond the Checkpoint.
    Cancer Res. 2026;86:1540-1542.
    PubMed         Abstract available
    
    

    
    Cancers (Basel)

18. ZHAO S, Yang X, Zhang L, Yang D, et al
    Correlation Between Dosimetric Parameters and Hematologic Toxicity in Cervical Cancer Patients Undergoing Intensity-Modulated Pelvic Radiotherapy.
    Cancers (Basel). 2026;18:992.
    PubMed         Abstract available
    
    

    
    Chem Biol Interact

19. MALISZEWSKI B, Ignaczak A, Skonieczna B, Pastuszynski A, et al
    Targeted delivery of doxorubicin via cholesteryl-modified cyclodextrin: Antitumor activity in breast, ovarian, and cervical cancer cell lines.
    Chem Biol Interact. 2026;432:112062.
    PubMed         Abstract available
    
    

    
    Clin Oncol (R Coll Radiol)

20. TAN LT, Gregory DL, Prewett S, Duke SL, et al
    Long-term Clinical Outcomes of a Resource-conserving Accelerated Magnetic Resonance Imaging-guided Brachytherapy Schedule for Cervix Cancer.
    Clin Oncol (R Coll Radiol). 2026;52:104057.
    PubMed         Abstract available
    
    

    
    Clin Ther

21. WU X, Zhang H, Yang X, Li Z, et al
    Rechallenging Immunotherapy With Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Achieved Partial Response in a Heavily Treated Patient With Metastatic Cervical Cancer: Case Report.
    Clin Ther. 2026 Mar 27:S0149-2918(26)00069.
    PubMed        
    
    

    
    Comput Biol Med

22. NARESH KUMAR A, Sageengran S, Mahalle PN, Guganathan L, et al
    Cervical cancer image analysis: Detection and segmentation using self-guided quantum GANs and musical chairs optimization.
    Comput Biol Med. 2026;208:111633.
    PubMed         Abstract available
    
    

    
    Cureus

23. TANG J, Oska C, Xie X, Small I, et al
    Impact of BMI on Organs at Risk Dose for Cervical Cancer Treated With Definitive Radiation Therapy Followed by Brachytherapy Boost.
    Cureus. 2026;18:e104301.
    PubMed         Abstract available
    
    

    
    Diagnostics (Basel)

24. PRETI M, Gallio N, Costa S, Borella F, et al
    Opportunistic and Organized Cervical Cancer Screening: Impact on Lesion Severity and Surgical Outcomes in 9830 Cervical Conizations.
    Diagnostics (Basel). 2026;16:839.
    PubMed         Abstract available
    
    

    
    Expert Rev Anticancer Ther

25. VIEIRA-BAPTISTA P, Lima-Silva J, Freitas G, Goncalves M, et al
    Impact of HPV vaccination after a diagnosis of cervical HSIL - a case-control study.
    Expert Rev Anticancer Ther. 2026;26:519-527.
    PubMed         Abstract available
    
    

    
    Expert Rev Mol Diagn

26. SINGH P, Sharma K, Tamrakar VK, Khare R, et al
    CRISPR-Cas system: recent advancements in prompt diagnosis of high-risk HPV genotypes in cervical cancer.
    Expert Rev Mol Diagn. 2026 Apr 1. doi: 10.1080/14737159.2026.2654503.
    PubMed         Abstract available
    
    

    
    FASEB J

27. ZHAO Z, Sun C, Liu X, Yu P, et al
    GSTO1 Promotes Cell Proliferation and Stemness of Cervical Cancer via Activating PI3K/AKT/mTOR Pathway.
    FASEB J. 2026;40:e71702.
    PubMed         Abstract available
    
    

    
    Front Cell Infect Microbiol

28. NAZAROVA V, Kamzayeva N, Ukybassova T, Kozhakhmetov S, et al
    Systems analysis of the HPV-microbiome-biofilm triad.
    Front Cell Infect Microbiol. 2026;16:1767224.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

29. XIAOYAN Z, Xiaojuan L, Shijiao M, Xiaofan Z, et al
    Baseline inflammatory and metabolic indicators associated with early PD-1 inhibitor resistance in advanced cervical cancer: a retrospective cohort study.
    Front Med (Lausanne). 2026;13:1779898.
    PubMed         Abstract available
    
    

    
    Front Oncol

30. LI S, Wang N
    The correlation between the triglyceride-glucose index and the odds of cervical cancer.
    Front Oncol. 2026;16:1766167.
    PubMed         Abstract available
    
    
31. LIU J, Ren WJ
    Durable progression-free survival with first-line sintilimab plus chemotherapy followed by sintilimab maintenance in PD-L1-high recurrent cervical cancer: a case report.
    Front Oncol. 2026;16:1736364.
    PubMed         Abstract available
    
    

    
    Front Pharmacol

32. FANG Y, Bai J, Bo S, Cui X, et al
    Targeting the AKT/mTOR axis: pectolinarigenin induces autophagy and apoptosis in human cervical cancer cells.
    Front Pharmacol. 2026;17:1544170.
    PubMed         Abstract available
    
    

    
    Front Surg

33. HUANG X, Zhou C, Ou Y
    Case Report: Fully transvaginal extraperitoneal pelvic lymphadenectomy via retropubic access combined with radical vaginal hysterectomy or trachelectomy for early-stage cervical cancer.
    Front Surg. 2026;13:1775199.
    PubMed         Abstract available
    
    

    
    Future Med Chem

34. ABBAS G, Bokhari TH, Iqbal MA, Rehman S, et al
    Mechanosynthesis and computational studies of new imidazole-based selenium adducts as potential anticancer agents against human prostate and cervical cancer.
    Future Med Chem. 2026 Mar 31:1-11. doi: 10.1080/17568919.2026.2648984.
    PubMed         Abstract available
    
    

    
    Future Oncol

35. DU Q, Liu Q, Zhou Y, Kong Y, et al
    Primary prophylaxis with pegylated G-CSF is associated with improved treatment completion and progression-free survival in locally advanced cervical cancer undergoing concurrent chemoradiotherapy: a retrospective cohort study.
    Future Oncol. 2026 Apr 3:1-10. doi: 10.1080/14796694.2026.2654729.
    PubMed         Abstract available
    
    
36. BROOK E, Patterson K, Wijenayake N, Madin-Warburton M, et al
    The broad societal value of pembrolizumab for women's cancer in Canada.
    Future Oncol. 2026;22:939-952.
    PubMed         Abstract available
    
    

    
    Genes (Basel)

37. ELSAYIM R, Alhamdi HW, Almuraikhi N, Alkhateeb MA, et al
    Multi-Omics Analysis of CDKN2A (p16INK4a) in Cervical Carcinoma in the Context of Human Papillomavirus and in Endometrial Carcinoma.
    Genes (Basel). 2026;17:281.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

38. CHALIF J, Morton M, Gonzalez A, McLaughlin E, et al
    Evaluation of immunotherapy response in the radiated field in patients with recurrent endometrial and cervical cancer.
    Gynecol Oncol. 2026;208:77-84.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol Rep

39. O'NEILL H, Bruegl A
    Immunotherapy induced sarcoidosis in a 47-year-old female with stage IIIC cervical cancer on pembrolizumab: A case report.
    Gynecol Oncol Rep. 2026;64:102062.
    PubMed         Abstract available
    
    

    
    Hum Vaccin Immunother

40. KITONSA J, Kafeero P, Ankunda V, Muhumuza R, et al
    Knowledge, perceptions, uptake, and determinants of HPV vaccination, and preferred delivery strategies among out-of-school girls in Masaka, Uganda.
    Hum Vaccin Immunother. 2026;22:2654928.
    PubMed         Abstract available
    
    

    
    IET Syst Biol

41. SHEN J, Miao Z, Wang L, Huo Z, et al
    Deep Learning Can Predict the Overall Survival of Cervical Cancer Based on Histopathological Image, Gene Mutation and Clinical Information.
    IET Syst Biol. 2026;20:e70060.
    PubMed         Abstract available
    
    

    
    Indian J Pathol Microbiol

42. GUPTA K, Mandal S, Singh M, Mala YM, et al
    The expression of p16 , epidermal growth factor receptor and CD44 in squamous cell carcinoma uterine cervix.
    Indian J Pathol Microbiol. 2026;69:48-53.
    PubMed         Abstract available
    
    

    
    Indian Pediatr

43. MOHAN N
    HPV Vaccination: A Transformative Step Towards Eliminating Cervical Cancer in India.
    Indian Pediatr. 2026 Mar 31. doi: 10.1007/s13312-026-00326.
    PubMed        
    
    

    
    Infect Agent Cancer

44. EMAGNENEH T, Mulugeta C, Ejigu B, Alamrew A, et al
    Burden and predictors of cervical cancer mortality in Sub-Saharan Africa: a systematic review and meta-analysis.
    Infect Agent Cancer. 2026 Mar 31. doi: 10.1186/s13027-026-00749.
    PubMed        
    
    

    
    Int J Biol Macromol

45. WANG H, Luo C, Chen W, Wang Y, et al
    Folic acid-decorated chitosan nanoparticles co-delivering silymarin and docetaxel induce CDK-mediated cell cycle arrest and apoptosis in cervical cancer cell.
    Int J Biol Macromol. 2026 Mar 25:151668. doi: 10.1016/j.ijbiomac.2026.151668.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

46. TJALMA W
    Letter to the Editor: Sentinel node biopsy in cervical cancer during pregnancy: The need for clarification in FIGO guidance.
    Int J Gynaecol Obstet. 2026 Mar 27. doi: 10.1002/ijgo.70986.
    PubMed        
    
    
47. DOMINONI M, Rasore G, Pano MR, Gardella B, et al
    "Side effects" of cervical cancer screening: How diagnosis can impact on women's emotional status. A pilot survey.
    Int J Gynaecol Obstet. 2026 Apr 2. doi: 10.1002/ijgo.71005.
    PubMed        
    
    

    
    Int J Nanomedicine

48. CHU C, Du Z, Wang J, Aili M, et al
    Targetable Biomimetic NIR-II Theranostic Nanoplatform for Highly Efficient Multimodal Imaging-Guided Photothermal Therapy of Cervical Cancer.
    Int J Nanomedicine. 2026;21:576589.
    PubMed         Abstract available
    
    

    
    Int J Technol Assess Health Care

49. MEIRELLES I, Pinto M, Russomano F
    Cost-utility of screening with liquid cytology or p16/Ki67 dual-stain in women identified in cervical cancer screening with non 16/18 HR-HPV.
    Int J Technol Assess Health Care. 2026.
    PubMed        
    
    

    
    Int J Womens Health

50. LI G, Chen N, Li X, Deng D, et al
    Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Urinary Retention After Radical Hysterectomy for Cervical Cancer: Study Protocol for A Pilot Randomized Controlled Trial.
    Int J Womens Health. 2026;18:595680.
    PubMed         Abstract available
    
    

    
    J Cancer Res Ther

51. GANDHI AK, Rastogi M, Sharma V, Bhutia TD, et al
    Doses to pelvic bone marrow from intracavitary brachytherapy in carcinoma cervix: A dosimetric study.
    J Cancer Res Ther. 2026;22:84-89.
    PubMed         Abstract available
    
    
52. SINDHU KR, Pranitha SL, Arpitha S, Narayanan GS, et al
    Impact of the revised FIGO 2018 staging system on survival outcomes with respect to prognostic factors in cervical cancer patients treated in a tertiary care cancer center in South Karnataka.
    J Cancer Res Ther. 2026;22:27-35.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

53. HAN KH, Yang E, Kim N, Son JH, et al
    Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study (GORILLA-1002).
    J Gynecol Oncol. 2026 Mar 12. doi: 10.3802/jgo.2026.
    PubMed         Abstract available
    
    
54. DUSHKIN A, Grishacheva T, Afanasiev S, Dushkina I, et al
    One more opportunity in early-stage cervical cancer: the role of photodynamic therapy in managing positive surgical margins.
    J Gynecol Oncol. 2026 Mar 18. doi: 10.3802/jgo.2026.
    PubMed         Abstract available
    
    

    
    J Med Internet Res

55. JI L, Zhou X, Yao L
    Factors Influencing Universal Coverage of AI-Assisted Cervical Cancer Screening: Qualitative Study Based on the Macro Model of Health System.
    J Med Internet Res. 2026;28:e75372.
    PubMed         Abstract available
    
    

    
    J Med Virol

56. MANICKAM R, Karnik M, Madhunapantula SV, Mohideen HS, et al
    Human CLIC5 as a Recurrent Hotspot of HPV 16 Integration in Cervical Cancer.
    J Med Virol. 2026;98:e70897.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

57. CASTLE PE
    Declining cervical cancer incidence in young women living in the United States: is it time to stop screening them?
    J Natl Cancer Inst. 2026 Mar 29:djag041. doi: 10.1093.
    PubMed        
    
    

    
    J Natl Compr Canc Netw

58. SU R, Wang Y
    CLO26-078: Impact of Laparoscopic Surgical Proficiency on Survival Outcomes in Laparoscopic Radical Hysterectomy for Cervical Cancer.
    J Natl Compr Canc Netw. 2026;24.
    PubMed        
    
    
59. CALDERON AM, Goyal S, Peddinani B, Lopez M, et al
    EPR26-154: Cervical Cancer Disparities in Hispanic Women: A Multilevel Analysis Using SEER and Texas State Data.
    J Natl Compr Canc Netw. 2026;24.
    PubMed        
    
    

    
    J Obstet Gynaecol Res

60. SATO K, Oshima N, Onuki M, Matsumoto K, et al
    Psychosocial Burden of Women With Cervical Intraepithelial Neoplasia in Japan: Results of A Web-Based Survey.
    J Obstet Gynaecol Res. 2026;52:e70258.
    PubMed         Abstract available
    
    

    
    J Radiat Res

61. ABE K, Ito K, Watanabe M, Tsuneda M, et al
    Feasibility of online adaptive SBRT boost with 1.5-T MR-Linac for cervical cancer patients unsuitable for brachytherapy: a planning study.
    J Radiat Res. 2026 Apr 1:rrag013. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Transl Med

62. TANG W, Ma H, Li J, Kuang Y, et al
    Targeting cell membrane sphingolipids: a novel ceramide analog CeY-B1 inhibits migration and invasion in cervical cancer cells.
    J Transl Med. 2026 Mar 28. doi: 10.1186/s12967-026-08031.
    PubMed        
    
    

    
    JMIR Form Res

63. ABUZOOR A, Jabin MSR, Jonker C
    Health Beliefs and Perspectives of Parents Regarding Human Papillomavirus Vaccination in Kuwait: Qualitative Study.
    JMIR Form Res. 2026;10:e85438.
    PubMed         Abstract available
    
    

    
    Life (Basel)

64. GIORGIO V, Del Dotto V, Grandi M, Grillini S, et al
    Pathogenic Mechanisms in Cervical Cancer: Energy Metabolism, Hypoxia and Therapy.
    Life (Basel). 2026;16:450.
    PubMed         Abstract available
    
    

    
    Med J Aust

65. YUILL S, Naidu C, Smith M, Bateson D, et al
    Cervical Cancer Elimination in Australia and the Asia Pacific: Progress and Barriers.
    Med J Aust. 2026;224:e70164.
    PubMed         Abstract available
    
    

    
    Med Phys

66. YAO Q, Wang K, Liu B, Jiang P, et al
    Integrated optimization of needle paths and dwell time for individualized template-guided interstitial brachytherapy.
    Med Phys. 2026;53:e70411.
    PubMed         Abstract available
    
    

    
    Med Sci (Basel)

67. PANCZEL I, Herold M, Borbenyi E, Horanyi D, et al
    Survival Difference in Advanced-Stage Cervical and Ovarian Cancer Patients Treated with Concomitant Modulated Electro-Hyperthermia in Comparison to Classic Treatment Modalities: Results of a Pilot Study and Meta-Analysis.
    Med Sci (Basel). 2026;14:105.
    PubMed         Abstract available
    
    

    
    Oncol Lett

68. LU X, Su Y, Xu W, Tang T, et al
    Efficacy of induction chemotherapy combined with standard chemoradiotherapy vs. standard chemoradiotherapy monotherapy in locally advanced cervical cancer: A systematic review and meta-analysis.
    Oncol Lett. 2026;31:183.
    PubMed         Abstract available
    
    

    
    Oncol Rep

69. LUO R, Chen J, Chen Z, Wang S, et al
    MS4322 is a selective protein arginine methyltransferase 5 degrader with antitumor effects in cervical cancer cells.
    Oncol Rep. 2026;55:101.
    PubMed         Abstract available
    
    

    
    Pharmaceuticals (Basel)

70. LI J, Parhat P, Ma Y, Peng L, et al
    Exploring the Anti-Cervical Cancer Effect and Hepatotoxicity Risk of Gossypol Based on Untargeted Metabolomics and Network Toxicology.
    Pharmaceuticals (Basel). 2026;19:377.
    PubMed         Abstract available
    
    
71. CSIKOS C, Ngo MT, Vagner A, Nagy G, et al
    Enhanced Tumor-to-Background Contrast with [(52)Mn]Mn-BPPA-Bevacizumab VEGF-Targeted Immuno-PET in Cervical Cancer.
    Pharmaceuticals (Basel). 2026;19:517.
    PubMed         Abstract available
    
    

    
    PLoS One

72. SHIRAKAWA S, Nagao S, Yoshio K, Mitsuhashi T, et al
    Incidence of pelvic fractures after definitive radiotherapy for cervical cancer: A retrospective multicenter cohort study (The IPFAR study).
    PLoS One. 2026;21:e0344384.
    PubMed         Abstract available
    
    

    
    Radiat Oncol

73. FEROZ B, Ebner C, Skvortsov S, Purtscheller R, et al
    Intensity-modulated radiotherapy/Volumetric modulated Arc therapy including four Brachytherapy fractions versus 3D conformal radiotherapy containing five Brachytherapy fractions in the treatment of cervical cancer.
    Radiat Oncol. 2026 Mar 31. doi: 10.1186/s13014-026-02834.
    PubMed        
    
    
74. SITTIWONG W, Prasartseree T, Tuntapakul P, Thaweerat W, et al
    Correction: Re-irradiation in oligorecurrence and oligometastatic cervical cancer in modern radiotherapy era.
    Radiat Oncol. 2026;21:42.
    PubMed        
    
    

    
    Radiol Imaging Cancer

75. TANAKA YO
    A Novel, Promising Technique for Metastatic Lymph Node Detection in Uterine Cervical Cancer.
    Radiol Imaging Cancer. 2026;8:e260111.
    PubMed        
    
    
76. BAO YH, Xiao ML, Li YA, Ma FH, et al
    Multiparametric MRI-based Deep Learning and Radiomics for Evaluating Lymph Node Metastasis in Early-Stage Cervical Cancer.
    Radiol Imaging Cancer. 2026;8:e250345.
    PubMed         Abstract available
    
    

    
    Recent Pat Anticancer Drug Discov

77. YI J, Xu C, Huo Z, Zhou H, et al
    MYH9 Promotes the Proliferation and Progression of Squamous Cervical Cancer Cells.
    Recent Pat Anticancer Drug Discov. 2026.
    PubMed         Abstract available
    
    

    
    Sci Rep

78. ENDALEW A, Kassahun M, Habtegiorgis SD, Tsega TD, et al
    Determinants of precancerous cervical lesion among HIV positive women on ART in Awi zone public health facilities, Northwest Ethiopia, 2024.
    Sci Rep. 2026;16:10729.
    PubMed         Abstract available
    
    
79. LUO J, Lin Y, Yi Q, Long Y, et al
    Efficacy of focused ultrasound for HPV clearance and cervical LSIL treatment: a meta-analysis.
    Sci Rep. 2026;16:10747.
    PubMed         Abstract available
    
    
80. HACHIMI SE, Essayagh F, Essayagh M, Kazadi GB, et al
    Assessing the prevalence of non-use of cervical cancer screening in Khouribga, Morocco.
    Sci Rep. 2026;16:10858.
    PubMed         Abstract available
    
    

    
    Support Care Cancer

81. GARG S, Udayashankara AH, S N, F HNA, et al
    Pain management and analgesic strategies in patients with carcinoma uterine cervix undergoing intracavitary or interstitial brachytherapy.
    Support Care Cancer. 2026;34:391.
    PubMed         Abstract available
    
    
82. ZHANG M, Gao L, Bai X
    Health-related hardiness and influencing factors among cervical cancer radiotherapy patients: A cross-sectional study.
    Support Care Cancer. 2026;34:394.
    PubMed         Abstract available
    
    

    
    Talanta

83. SAINI K, Saini A, Yadav N, Kumar V, et al
    Emerging frontiers in cervical cancer diagnostics: Recent innovations in biosensors for HPV detection.
    Talanta. 2026;306:129750.
    PubMed         Abstract available
    
    

    
    Vaccine

84. SATAKE M, Ito S, Sawano C, Scuffham P, et al
    Benefit-risk assessment of HPV vaccination programs in Australia, the United States, and Japan.
    Vaccine. 2026;78:128407.
    PubMed         Abstract available
    
    

    
    Vaccines (Basel)

85. BIEDERMAN EB, Champion VL, Head KJ, Imburgia TM, et al
    Correlates of Integrated Human Papillomavirus Vaccination and Cervical Cancer Screening Protection in U.S. Low-Income Women.
    Vaccines (Basel). 2026;14:251.
    PubMed         Abstract available
    
    

    
    Yakugaku Zasshi

86. NAKAJIMA K, Otsuka Y, Ikejiri T, Hakariya H, et al
    Evaluating the "Praise Movement" on Social Media: Perceptions of the Human Papillomavirus Vaccine in Japan.
    Yakugaku Zasshi. 2026;146:339-343.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum